The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this project is to examine the effects of varenicline treatment used concomitantly with antipsychotic medications, on cognitive dysfunction in people with schizophrenia. The secondary objective is to evaluate the effect of this combination therapy on smoking in people with schizophrenia. This study will be a randomized, double blind, parallel group, placebo controlled 8 weeks trial.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Inje University
• Collaborator: Stanley Medical Research Institute
• Treatments: Varenicline

Criteria

Inclusion Criteria:

• Clinically stable patients with schizophrenia

Exclusion Criteria:

• Refractory schizophrenia

• Mental Retardation

• Serious Medical illness